arginine has been researched along with hydralazine in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 13 (56.52) | 18.2507 |
| 2000's | 7 (30.43) | 29.6817 |
| 2010's | 3 (13.04) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Chaudhuri, G; Cuevas, JM; Ignarro, LJ; Vargas, HM | 1 |
| Hackenthal, E; Münter, K | 1 |
| Egashira, K; Kadokami, T; Numaguchi, K; Shimokawa, H; Sueishi, K; Takemoto, M; Takeshita, A | 1 |
| Adams, ML; Cicero, TJ; Meyer, ER; Sewing, BN | 1 |
| Boura, AL; Leitch, IM; Read, MA; Walters, WA | 1 |
| Berkenboom, G; Brékine, D; Fontaine, J; Grosfils, K; Staroukine, M; Unger, P | 1 |
| Howe, PR; Jablonskis, LT | 1 |
| Fujino, H; Ikeda, K; Kubota, A; Nara, Y; Numano, F; Tagami, M; Yamori, Y | 1 |
| Hajj-Ali, AF; Reilly, TM; Wong, PC | 1 |
| Bennett, T; Gardiner, SM; Kemp, PA; Moncada, S; Palmer, RM | 1 |
| Calle, A; Jácome, P; López-Jaramillo, P; Narváez, M; Nava, E; Rivera, J; Ruano, C | 1 |
| Bennett, MA; Hillier, C; Thurston, H | 1 |
| Andoh, TF; Bennett, WM; Couser, WG; Johnson, RJ; Pichler, RH; Shankland, SJ; Thomas, SE | 1 |
| Abe, Y; Chen, QH; Kosaka, H; Tian, RX; Yamamoto, A; Yoneyama, H; Zhang, L; Zhou, MS | 1 |
| Chowdhary, S; Coote, JH; Nuttall, SL; Townend, JN | 1 |
| Inagi, R; Ishikawa, N; Koike, H; Kurokawa, K; Miyata, T; Mizuno, M; Nangaku, M; Sada, T; Ueda, Y; van Ypersele de Strihou, C; Yuzawa, H | 1 |
| de Moura, RS; Ferraz, MM; Ferraz, MR; Santos, R | 1 |
| Czap, A | 1 |
| André, C; Bagnost, T; Berthelot, A; Bouhaddi, M; Demougeot, C; Guillaume, Y; Marie, C; Prigent-Tessier, A | 1 |
| Dubinion, JH; Jackson, EK; Mi, Z | 1 |
| Cao, Y; Fang, Y; Liu, FQ; Mu, JJ; Yuan, ZY | 1 |
1 review(s) available for arginine and hydralazine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for arginine and hydralazine
| Article | Year |
|---|---|
L-arginine augments cardiac vagal control in healthy human subjects.
Topics: Adult; Arginine; Baroreflex; Blood Pressure; Cross-Over Studies; Female; Heart; Heart Rate; Humans; Hydralazine; Male; Nitric Oxide; Single-Blind Method; Stereoisomerism; Vagus Nerve; Vasodilator Agents | 2002 |
21 other study(ies) available for arginine and hydralazine
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Comparison of the inhibitory potencies of N(G)-methyl-, N(G)-nitro- and N(G)-amino-L-arginine on EDRF function in the rat: evidence for continuous basal EDRF release.
Topics: Acetylcholine; Animals; Aorta, Thoracic; Arginine; Blood Pressure; Hydralazine; In Vitro Techniques; Male; Nitrates; Nitric Acid; Nitric Oxide; Nitroarginine; omega-N-Methylarginine; Penicillamine; Phenylephrine; Rats; Rats, Inbred Strains; S-Nitroso-N-Acetylpenicillamine; Sympathetic Nervous System; Vasodilation; Vasopressins | 1991 |
The participation of the endothelium in the control of renin release.
Topics: Acetylcholine; Animals; Arginine; Dose-Response Relationship, Drug; Endothelium, Vascular; Hydralazine; In Vitro Techniques; Kidney; Male; Nitric Oxide; Rats; Rats, Inbred Strains; Renin; Vasoconstriction | 1991 |
Chronic inhibition of nitric oxide synthesis causes coronary microvascular remodeling in rats.
Topics: Animals; Arginine; Blood Pressure; Cardiomegaly; Coronary Circulation; Coronary Vessels; Data Interpretation, Statistical; Enzyme Inhibitors; Fibrosis; Heart; Heart Rate; Histological Techniques; Hydralazine; Hypertension; Male; Microcirculation; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Rats; Rats, Inbred WKY | 1995 |
Effects of nitric oxide-related agents on rat testicular function.
Topics: Amino Acid Oxidoreductases; Animals; Arginine; Drug Interactions; Hydralazine; Isosorbide Dinitrate; Male; NG-Nitroarginine Methyl Ester; Nicardipine; Nitric Oxide; Nitric Oxide Synthase; Rats; Rats, Sprague-Dawley; Steroids; Stimulation, Chemical; Testis; Testosterone; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents | 1994 |
Effect of inhibition of nitric oxide synthase and guanylate cyclase on hydralazine-induced vasodilatation of the human fetal placental circulation.
Topics: Adolescent; Adult; Amino Acid Oxidoreductases; Aminoquinolines; Arginine; Blood Pressure; Dose-Response Relationship, Drug; Embryonic and Fetal Development; Female; Guanylate Cyclase; Heart Rate, Fetal; Humans; Hydralazine; In Vitro Techniques; Linear Models; Nitric Oxide Synthase; Nitroarginine; Perfusion; Placenta; Potassium Chloride; Pregnancy; Vasoconstriction; Vasodilation | 1994 |
Chronic angiotensin-converting enzyme inhibition and endothelial function of rat aorta.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Arginine; Bradykinin; Cyclic GMP; Drug Synergism; Endothelium, Vascular; Hydralazine; Male; Nitric Oxide; omega-N-Methylarginine; Peptidyl-Dipeptidase A; Ramipril; Rats; Rats, Wistar; Vasodilation | 1995 |
Plasma adrenaline responses to long-term modification of blood pressure in normotensive rats and hypertensive rats.
Topics: Animals; Arginine; Blood Pressure; Epinephrine; Hydralazine; Hypertension; Male; NG-Nitroarginine Methyl Ester; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Time Factors | 1995 |
Detailed examination of vascular lesions triggered by an inhibitor of endothelium-derived relaxing factor.
Topics: Animals; Arginine; Arterial Occlusive Diseases; Blood Pressure; Blood Vessels; Cerebrovascular Disorders; Dose-Response Relationship, Drug; Hydralazine; Hypertension, Renovascular; Incidence; Microscopy, Electron; Nitric Oxide; Nitroarginine; Potassium; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Sodium; Thrombosis; Time Factors; Vascular Diseases | 1995 |
Modulation of renal vasoconstrictor effect of NG-nitro-L-arginine in rabbit by angiotensin II and alpha-1 adrenergic receptor blockade.
Topics: Adrenergic alpha-Antagonists; Angiotensin II; Animals; Antibodies; Arginine; Biphenyl Compounds; Drug Interactions; Hemodynamics; Hydralazine; Imidazoles; Kidney; Losartan; Male; Nitroarginine; Prazosin; Rabbits; Tetrazoles; Vasoconstrictor Agents | 1994 |
Regional and cardiac haemodynamic effects of NG, NG,dimethyl-L-arginine and their reversibility by vasodilators in conscious rats.
Topics: Animals; Arginine; Glutathione; Hemodynamics; Hydralazine; Male; Nitroprusside; Nitroso Compounds; omega-N-Methylarginine; Penicillamine; Rats; S-Nitroso-N-Acetylpenicillamine; S-Nitrosoglutathione; Vasodilator Agents | 1993 |
Cyclic guanosine 3',5' monophosphate concentrations in pre-eclampsia: effects of hydralazine.
Topics: Adult; Arginine; Birth Weight; Blood Pressure; Cyclic GMP; Female; Humans; Hydralazine; Nitric Oxide; Pre-Eclampsia; Pregnancy; Vasodilator Agents | 1996 |
Endothelium-dependent relaxation in resistance arteries from spontaneously hypertensive rats: effect of long-term treatment with perindopril, quinapril, hydralazine or amlodipine.
Topics: Acetylcholine; Amlodipine; Animals; Antihypertensive Agents; Arginine; Bradykinin; Dose-Response Relationship, Drug; Endothelium, Vascular; Hydralazine; Hypertension; Indoles; Isoquinolines; Mesenteric Arteries; Nitroarginine; Perindopril; Quinapril; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Tetrahydroisoquinolines; Vasodilation | 1996 |
Accelerated apoptosis characterizes cyclosporine-associated interstitial fibrosis.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Apoptosis; Arginine; Biotin; Cyclosporine; Deoxyuracil Nucleotides; DNA Fragmentation; Enzyme Inhibitors; Fibrosis; Hydralazine; Immunosuppressive Agents; Ischemia; Kidney; Losartan; Macrophages; Male; Nephritis, Interstitial; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Staining and Labeling | 1998 |
L-Arginine improves endothelial function in renal artery of hypertensive Dahl rats.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Acetylcholine; Animals; Arginine; Blood Pressure; Bridged Bicyclo Compounds, Heterocyclic; Cyclic GMP; Endothelins; Endothelium, Vascular; Fatty Acids, Unsaturated; Hydralazine; Hydrazines; Hypertension; In Vitro Techniques; Indomethacin; Male; Methacrylates; Natriuresis; Nitrates; Nitrites; Nitroprusside; Rats; Rats, Inbred Dahl; Renal Artery; Thromboxane A2; Vasoconstriction | 2001 |
Anti-hypertensive agents inhibit in vivo the formation of advanced glycation end products and improve renal damage in a type 2 diabetic nephropathy rat model.
Topics: Animals; Antihypertensive Agents; Arginine; Blood Glucose; Blood Pressure; Body Weight; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disease Models, Animal; Glycation End Products, Advanced; Hydralazine; Hypertension, Renal; Imidazoles; Immunohistochemistry; In Vitro Techniques; Kidney; Lipids; Lysine; Male; Olmesartan Medoxomil; Oxidation-Reduction; Proteinuria; Rats; Tetrazoles | 2003 |
Preventing L-NAME inhibitory effects on rat sexual behavior with hydralazine, isradipine or captopril co-treatment.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Arginine; Captopril; Drug Interactions; Ejaculation; Enzyme Inhibitors; Female; Hydralazine; Isradipine; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Rats; Rats, Wistar; Sexual Behavior, Animal; Time Factors; Vasodilator Agents | 2003 |
Color blind, or just plain blind?
Topics: Arginine; Black People; Delayed-Action Preparations; Drug Combinations; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Nitric Oxide; Pharmacogenetics; Vasodilator Agents | 2005 |
Time course of vascular arginase expression and activity in spontaneously hypertensive rats.
Topics: Animals; Antihypertensive Agents; Aorta, Thoracic; Arginase; Arginine; Blood Pressure; Body Weight; Hydralazine; Hypertension; Interleukin-6; Male; Nitric Oxide; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Time Factors | 2007 |
Effects of dipeptidyl peptidase iv inhibition on arterial blood pressure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Arginine; Blood Pressure; Captopril; Chlorisondamine; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Ganglionic Blockers; Hydralazine; Hypertension; Pentanoic Acids; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, Neuropeptide Y; Thiazolidines; Vasodilator Agents | 2008 |
Impact of high salt independent of blood pressure on PRMT/ADMA/DDAH pathway in the aorta of Dahl salt-sensitive rats.
Topics: Amidohydrolases; Animals; Antihypertensive Agents; Aorta; Arginine; Blood Pressure; Hydralazine; Hypertension; Male; Nitric Oxide; Nitric Oxide Synthase Type III; Protein-Arginine N-Methyltransferases; Rats; Rats, Inbred Dahl; RNA, Messenger; Signal Transduction; Sodium Chloride, Dietary | 2013 |